|
|
Precision micro-filling of API into capsules – equates to low waste of API
|
|
|
|
Records the weight of drug in each capsule – allowing traceability of samples
that meet GMP requirements.
|
|
|
|
Removes the need for excipients that are normally required for filling purposes
and associated stability studies
|
|
|
|
Faster time to ‘first-in-human' studies
|
|
|
|
Products to suit both pre-clinical, clinical trial filling requirements and
small-scale product manufacturing
|
|
|
|
Eliminates drug/excipient compatibility issues
|
|
|
|
Reduces pre-formulation time and effort
|
|
|
|
Creates flexibility needed for dose ranging doses
|
|
|
|
Simplifies development of drug product stability indicating assays
|
|
|
|
Simplifies stability protocols
|
|
|
|
Drug substance is fully retrievable
|
|
|
|
Minimizes drug loss
|